Sep 13, 2019

A presentation on follicular lymphoma featuring perspectives from Dr John P Leonard.

• Introduction
  • Program Overview: Dr Leonard (00:00)
• Optimizing the Care of Patients with Newly Diagnosed Follicular Lymphoma (FL)
  • Initiation of active therapy versus watchful waiting; indications for rituximab monotherapy (00:34)
  • Choice of systemic therapy for patients requiring treatment; impact of age, tumor bulk and symptomatology (3:55)
  • Clinical research data evaluating maintenance therapy; factors influencing its use (15:41)
  • Data for and clinical role of subcutaneous rituximab (20:29)
• Management of Relapsed/Refractory (R/R) FL
  • Factors affecting the sequencing of systemic therapy for R/R disease (eg, previous treatment received, remission duration, symptomatology) (22:37)
  • Integration of obinutuzumab in the R/R setting (25:50)
  • Role of lenalidomide/rituximab in the management of R/R FL (28:54)
  • Available clinical research data with the FDA-approved PI3K inhibitors (34:41)

CME information and select publications